跳至主要内容
临床试验/NCT03006341
NCT03006341已完成不适用

Validation of Predictors for Oral Anticoagulant Medication Choice Using EMR Data

Boehringer Ingelheim1 个研究点 分布在 1 个国家目标入组 140,187 人开始时间: 2017年2月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
140,187
试验地点
1
主要终点
Percentage of Patients With Alcohol Consumption

研究概览

简要总结

The objectives of this study are, first, to identify select clinical covariates from electronic medical records (EMR) that might be associated with initiation of oral anticoagulant medications (dabigatran or warfarin) in patients with non-valvular atrial fibrillation (NVAF) at risk for stroke; second, to quantify the association between EMR-based clinical characteristics and patterns of insurance claims; third, to assess the potential for unmeasured confounding in dabigatran vs warfarin comparative effectiveness and safety studies based on administrative claims databases.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First dispensing of warfarin or dabigatran between October 2010 and December 2014
  • Diagnosis of atrial fibrillation
  • ≥ 12 months enrolment in the database preceding the date of the first dispensing
  • Congestive Heart Failure, Hypertension, Age > 75, Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack, Vascular Disease (CHA2DS2-VASc) score ≥ 1

排除标准

  • Prior use of oral anticoagulation
  • Evidence of valvular atrial fibrillation
  • Missing or ambiguous age or sex information
  • Patients with a nursing home stay during baseline

研究组 & 干预措施

Dabigatran etexilate

NVAF patients initiating dabigatran etexilate

干预措施: Dabigatran etexilate (Drug)

Warfarin

NVAF patients initiating warfarin

干预措施: Warfarin (Drug)

结局指标

主要结局

Percentage of Patients With Alcohol Consumption

时间窗: Up to 12 months

Percentage of patients with alcohol consumption in the electronic medical records (EMR) are presented. The patients with light to moderate, heavy and unknown quantity of alcohol consumption are considered. The results are provided before and after propensity score (PS) matching. Before PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR whose data were available; After PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR, 1:1 propensity score matched, whose data were available.

Percentage of Patients With Abnormal Renal Function

时间窗: Up to 12 months

Percentage of patients with abnormal renal function; defined as "Any note of: Dialysis, renal transplant Serum Creatinine \>1.3 Milligrams per Deciliter (mg/dL) in the electronic medical records (EMR)". Response was considered to be truly absent if not recorded in the EMR. The results are provided before and after propensity score (PS) matching. Before PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR whose data were available; After PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR, 1:1 propensity score matched, whose data were available.

Percentage of Patients Smoking

时间窗: Up to 12 months

Percentage of patients with current/past smoking in the electronic medical records (EMR) are presented. The results are provided before and after propensity score (PS) matching. Before PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR whose data were available; After PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR, 1:1 propensity score matched, whose data were available.

Percentage of Patients With Bleeding History or Predisposition

时间窗: Up to 12 months

Percentage of patients with bleeding history or predisposition is presented, defined as any note of major bleeding requiring hospitalization or blood transfusion or causing a decrease in hemoglobin level of \> 2 gram per liter (g/L) in the electronic medical records (EMR). Response was considered to be truly absent if not recorded in the EMR. The results are provided before and after propensity score (PS) matching. Before PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR whose data were available; After PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR, 1:1 propensity score matched, whose data were available.

Percentage of Patients With Obesity

时间窗: Up to 12 months

Percentage of patients with obesity; where obesity is defined as "obese, not-obese based on note of obesity or recorded body mass index (BMI) \> 30 in the electronic medical records (EMR)". The results are provided before and after propensity score (PS) matching. Before PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR whose data were available; After PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR, 1:1 propensity score matched, whose data were available.

EMR Characteristic: Serum Creatinine

时间窗: Up to 12 months

EMR characteristic: Serum Creatinine closest to index dispensing. The results are provided before and after propensity score (PS) matching. Before PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR whose data were available; After PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR, 1:1 propensity score matched, whose data were available.

Percentage of Patients With Abnormal Liver Function

时间窗: Up to 12 months

Percentage of patients with abnormal liver function; defined as "Any note of: Liver disease, cirrhosis, Active hepatitis C, Active hepatitis B, Active hepatitis A, aspartate transaminase/alanine transaminase (AST/ALT) \>3 times upper limit of normal in the electronic medical records (EMR). Absence of any note would be considered as absence of the disease". Response was considered to be truly absent if not recorded in the EMR. The results are provided before and after propensity score (PS) matching. Before PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR whose data were available; After PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR, 1:1 propensity score matched, whose data were available.

EMR Characteristic: Renal Function - Glomerular Filtration Rate (GFR)

时间窗: Up to 12 months

EMR characteristic: Renal function - Glomerular Filtration Rate (GFR). Estimated GFR closest to index dispensing. The results are provided before and after propensity score (PS) matching. Before PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR whose data were available; After PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR, 1:1 propensity score matched, whose data were available.

次要结局

  • EMR Characteristic: Duration of Atrial Fibrillation(Up to 12 months)
  • Percentage of Patients With Prior Transient Ischemic Attack(Up to 12 months)
  • Percentage of Patients With Hyperlipidemia(Up to 12 months)
  • Percentage of Patients With Diabetes(Up to 12 months)
  • EMR Characteristic: History/Duration of Hypertension(Up to 12 months)
  • EMR Characteristic: History/Duration of Congestive Heart Failure (CHF)(Up to 12 months)
  • Percentage of Patients With Use of Antiplatelets or Non-steroidal Anti-inflammatory Drugs(Up to 1 month)
  • EMR Characteristic: History of Adherence: Non-adherent/Adherent(Up to 12 months)
  • Percentage of Patients With Uncontrolled Hypertension(Up to 12 months)
  • EMR Characteristic: Hypertension, Abnormal Liver/Renal Function, Stroke, Bleeding History or Predisposition, Labile International Normalized Ratio, Elderly, Drugs/Alcohol Usage (HAS-BLED) Score(Up to 12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Validation of Predictors of OAC Initiation Using EMR... | 临床试验